News

Technology News

Invirion Diagnostics Launches New Molecular Platform

Tuesday, December 16, 2008 5:16:00 AM PDT | VentureDeal Staff
Oak Brook, Illinois  --  Research diagnostics company Invirion Diagnostics announced the launch of a new molecular hybrid platform.

The company's hybrid platform is an instrument that "allows clinicians to perform solution based and cell-based molecular diagnostics."

Invirion was founded in 1999 with the goal of commercializing molecular virology technology for the detection, monitoring and treatment of viral diseases such as HIV/AIDS, hepatitis, cervical cancer and organ transplant rejection.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.